Jul 12, 2024 · Early detection of myasthenia gravis, along with timely treatment, could mitigate symptom severity and optimize outcomes, reports Dr Nicholas Silvestri.

Oct 18, 2024 · SAVANNAH, GEORGIA — One patient with autoimmune myasthenia gravis (MG) has a niece with the same diagnosis, and at least one of his other close relatives may have it too. Another …

Jun 28, 2024 · Myasthenia gravis, a rare autoimmune disease, can have devastating consequences. Stay current on the latest and emerging MG treatments with these five things to know.

New phase 3 data show meaningful improvement in antibody-negative myasthenia gravis, for which treatment options are limited and patients face persistent unmet clinical needs.

Apr 3, 2024 · Neurologists Kathrin LaFaver and Kim Robeson-Gewuerz discuss what tests and treatments you should consider when myasthenia gravis is suspected.

Apr 30, 2025 · Highlights in myasthenia gravis from AAN 2025 include trials of new therapy inebilizumab, new data on the approved rozanolixizumab for ocular symptoms, and insights into …

Myasthenia gravis updates from AANEM 2025 include efficacy data for efgartigimod, telitacicept, and gefurulimab, plus interim results for a CAR T-cell therapy and DNTH10, an active C1S inhibitor.

Dr Katherine Ruzhansky recounts how new diagnostic biomarkers and therapies are improving outcomes for patients with myasthenia gravis.

Feb 16, 2021 · Myasthenia gravis is a disorder of neuromuscular transmission, resulting from autoantibodies to components of the neuromuscular junction, most commonly the acetylcholine …

Mar 13, 2024 · Treatment with the investigational monoclonal antibody drug batoclimab significantly improved symptoms in patients with antibody-positive generalized myasthenia gravis (MG), data …